Clinical Evaluation of the Nucleus 5 Cochlear Implant (CI) System

Completed · Not applicable

Conditions studied: Hearing Loss

In brief

To evaluate the performance of the Nucleus 5 Cochlear Implant System.

Key facts

Study ID

NCT01072409

Run by

Cochlear

People needed

49

Starts

2010-03-01

Expected to finish

2012-11-01

Last updated by the study team

2016-10-27

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Eighteen years of age or older at the time of the study.
• Postlinguistic onset of bilateral severe-to-profound sensorineural hearing loss
• Bilateral severe-to-profound hearing loss that meets current cochlear implant criteria (<50% open-set sentence recognition in quiet scores in the ear to be implanted and <60% in the best-aided condition)
• English spoken as the primary language.
• Willingness to participate in and to comply with all requirements of the study
• Subject may receive bilateral simultaneous cochlear implants.

You may not qualify if…

• Previous cochlear implant experience
• Congenital hearing loss (for the purpose of this study, onset prior to 2 years-of-age).
• Ossification, absence of cochlear development or any other cochlear anomaly that might prevent complete insertion of the electrode array.
• Normal hearing in one or both ears.
• Hearing loss of neural or central origin (e.g., deafness due to lesions on the acoustic nerve or central auditory pathway).
• Active middle-ear infection.
• Unwillingness and/or inability of the candidate to comply with all investigational requirements including, but not limited to, study protocol and surgical procedure.

Where it is running

• University of Michigan — Ann Arbor, Michigan, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.